A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer
Open Access
- 14 September 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-12
Abstract
Combining anti-cancer agents in cancer therapies is becoming increasingly popular due to improved efficacy, reduced toxicity and decreased emergence of resistance. Here, we test the hypothesis that dietary agents such as oligomeric proanthocyanidins (OPCs) and curcumin cooperatively modulate cancer-associated cellular mechanisms to inhibit carcinogenesis. By a series of in vitro assays in colorectal cancer cell lines, we showed that the anti-tumorigenic properties of the OPCs-curcumin combination were superior to the effects of individual compounds. By RNA-sequencing based gene-expression profiling in six colorectal cancer cell lines, we identified the cooperative modulation of key cancer-associated pathways such as DNA replication and cell cycle pathways. Moreover, several pathways, including protein export, glutathione metabolism and porphyrin metabolism were more effectively modulated by the combination of OPCs and curcumin. We validated genes belonging to these pathways, such as HSPA5, SEC61B, G6PD, HMOX1 and PDE3B to be cooperatively modulated by the OPCs-curcumin combination. We further confirmed that the OPCs-curcumin combination more potently suppresses colorectal carcinogenesis and modulated expression of genes identified by RNA-sequencing in mice xenografts and in colorectal cancer patient-derived organoids. Overall, by delineating the cooperative mechanisms of action of OPCs and curcumin, we make a case for the clinical co-administration of curcumin and OPCs as a treatment therapy for patients with colorectal cancer.Keywords
Funding Information
- National Institutes of Health (CA72851, CA181572, CA184792, CA187956 and CA202797)
This publication has 67 references indexed in Scilit:
- Evolutionary dynamics of cancer in response to targeted combination therapyeLife, 2013
- Correction to “Small-Molecule Targeting of Proliferating Cell Nuclear Antigen Chromatin Association Inhibits Tumor Cell Growth”Molecular Pharmacology, 2013
- FLEXBAR—Flexible Barcode and Adapter Processing for Next-Generation Sequencing PlatformsBiology, 2012
- Molecular mechanisms of curcumin action: Gene expressionBioFactors, 2012
- GENCODE: The reference human genome annotation for The ENCODE ProjectGenome Research, 2012
- Small-Molecule Targeting of Proliferating Cell Nuclear Antigen Chromatin Association Inhibits Tumor Cell GrowthMolecular Pharmacology, 2012
- An Overview of Cancer Chemopreventive Potential and Safety of ProanthocyanidinsNutrition and Cancer, 2011
- Suppression of Cancer Cell Growth by Promoting Cyclin D1 DegradationMolecular Cell, 2009
- The Sequence Alignment/Map format and SAMtoolsBioinformatics, 2009
- Chemical combination effects predict connectivity in biological systemsMolecular Systems Biology, 2007